NSIS-B:CPH
Novozymes A/S
DKK 454.80
arrow_downward
-0.70%(-3.20) 1D
Oct 16, 5:00:00 PM GMT+2 · DKK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NSIS-B...
Open
DKK 452.80
High
DKK 456.80
Low
DKK 452.00
Mkt. cap
188.58B
Avg. vol.
605.45K
Volume
0.00
52-wk high
DKK 465.00
52-wk low
DKK 336.80
Shares outstanding
414.56M
No. of employees
11K
Open
DKK 452.80
High
DKK 456.80
Low
DKK 452.00
Mkt. cap
188.58B
Avg. vol.
605.45K
Volume
0.00
52-wk high
DKK 465.00
52-wk low
DKK 336.80
Shares outstanding
414.56M
No. of employees
11K
News stories
From web sources and news partners
Yahoo Finance
·
17 minutes ago
Sandisk Is Dominating the S&P 500 in 2026. Can It Repeat in 2027?
Yahoo Finance
·
1 hour ago
The S&P 500's "Average" Year Almost Never Happens. Here's How Often It Actually Lands Near 10%.
FOREX.com
·
2 hours ago
S&P 500, Nasdaq, Dow and Russell 2000 For the Week Ahead
디지털투데이
·
7 hours ago
Bitcoin could fall to $10,000 if S&P 500 drops 20 percent - Bloomberg
Profile
Novozymes A/S is a Danish biotechnology company. Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen.
The company develops enzymes, microbial cultures, and other biological products used in food and beverage production, household products, agriculture, and bioenergy.
The merger, first announced in December 2022, was the largest merger in history between two Danish companies. It would combine Novozymes' industrial-enzyme business with Chr. Hansen's microbial cultures and food-ingredient operations.
The company is publicly traded on Nasdaq Copenhagen and is part of the OMX Copenhagen 25 Index. The company's largest shareholder is Novo Holdings, which is owned by the Novo Nordisk Foundation.
As of 2025, Novonesis has approximately 11,600 employees and activities in over 45 countries. Wikipedia
About Novozymes A/S